Seilern America GBP U IRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 24.9 | 27.6 | -18.0 | 19.2 | 0.2 | |
+/-Cat | -6.3 | 5.7 | 3.6 | -7.5 | -7.3 | |
+/-B’mrk | -7.0 | 0.3 | 5.3 | -12.8 | -8.6 | |
Category: US Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar US LM Brd Growt... |
Key Stats | ||
NAV 14/05/2024 | GBP 231.47 | |
Day Change | 0.13% | |
Morningstar Category™ | US Large-Cap Growth Equity | |
IA (formerly IMA) Sector | North America | |
ISIN | IE00BF5H4N14 | |
Fund Size (Mil) 14/05/2024 | USD 374.81 | |
Share Class Size (Mil) 14/05/2024 | GBP 5.18 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 23/02/2024 | 0.90% |
Investment Objective: Seilern America GBP U I |
The investment objective of the fund is to seek capital appreciation through investment in equity or equity related securities (i.e. equity warrants and convertible bonds) of the issued by high quality companies listed on the stock exchanges of countries within the OECD. Investment will be made predominantly in the equities of issuers established in the U.S. and North American OECD member countries. The fund may purchase securities denominated in any of the major convertible currencies of the member countries of the OECD. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Corentin Massin 18/05/2018 | ||
Quentin Macfarlane 01/05/2019 | ||
Inception Date 23/03/2018 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P 500 TR USD | Morningstar US LM Brd Growth NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Seilern America GBP U I | 31/01/2024 |
|
|
Top 5 Holdings | Sector | % |
Microsoft Corp | Technology | 7.52 |
Mastercard Inc Class A | Financial Services | 7.15 |
West Pharmaceutical Services Inc | Healthcare | 6.07 |
UnitedHealth Group Inc | Healthcare | 5.94 |
IDEXX Laboratories Inc | Healthcare | 5.54 |
Increase Decrease New since last portfolio | ||
Seilern America GBP U I |